Complete Filing Data
Veralto Corp reported Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents of $2.03 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Veralto Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Selling General And Administrative Expense | $1.76B | $1.64B | $1.54B | $1.43B | $1.43B |
| Revenue From Contract With Customer Excluding Assessed Tax | $5.50B | $5.19B | $5.02B | $4.87B | $4.70B |
| Research And Development Expense | $266.0M | $253.0M | $225.0M | $217.0M | $244.0M |
| Other Nonoperating Income Expense | -$8.0M | -$9.0M | -$14.0M | $1.0M | $6.0M |
| Other Comprehensive Income Loss Net Investment Hedge Gain Loss Net Of Tax Attributable To Parent | -$60.0M | $26.0M | -$14.0M | $0.00 | $0.00 |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $220.0M | -$139.0M | $29.0M | -$100.0M | -$88.0M |
| Operating Income Loss | $1.28B | $1.21B | $1.14B | $1.11B | $1.04B |
| Net Income Loss | $940.0M | $833.0M | $839.0M | $845.0M | $861.0M |
| Income Tax Expense Benefit | $233.0M | $253.0M | $257.0M | $268.0M | $186.0M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $1.17B | $1.09B | $1.10B | $1.11B | $1.05B |
| Gross Profit | $3.30B | $3.11B | $2.90B | $2.76B | $2.71B |
| Cost Of Goods And Services Sold | $2.20B | $2.09B | $2.12B | $2.11B | $1.99B |
| Comprehensive Income Net Of Tax | $1.10B | $716.0M | $839.0M | $778.0M | $788.0M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$117.0M | $0.00 | -$67.0M | -$73.0M | |
| Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent | $2.0M | $4.0M | $15.0M | -$33.0M | -$15.0M |
| Amortization Of Intangible Assets | $36.0M | $38.0M | $48.0M | $50.0M | $62.0M |
| Interest Expense Nonoperating | $96.0M | $113.0M | $30.0M | $0.00 | |
| Interest Expense | $30.0M | $0.00 | $0.00 | ||
| Income Taxes Paid Net | $235.0M | $293.0M | $113.0M | $0.00 | |
| Equity Method Investment Other Than Temporary Impairment | $0.00 | $15.0M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Selling General And Administrative Expense | $451.0M | $442.0M | $419.0M | $412.0M | $414.0M | $394.0M | $395.0M | $378.0M | $360.0M | $357.0M |
| Revenue From Contract With Customer Excluding Assessed Tax | $1.40B | $1.37B | $1.33B | $1.31B | $1.29B | $1.25B | $1.26B | $1.25B | $1.23B | $1.22B |
| Research And Development Expense | $67.0M | $67.0M | $64.0M | $63.0M | $61.0M | $60.0M | $55.0M | $57.0M | $56.0M | $52.0M |
| Other Nonoperating Income Expense | $1.0M | $0.00 | -$6.0M | $5.0M | $1.0M | -$15.0M | $0.00 | -$14.0M | $0.00 | $0.00 |
| Other Comprehensive Income Loss Net Investment Hedge Gain Loss Net Of Tax Attributable To Parent | -$6.0M | -$32.0M | -$22.0M | -$18.0M | $3.0M | $9.0M | $3.0M | $0.00 | $0.00 | $0.00 |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$34.0M | $153.0M | $81.0M | $88.0M | -$29.0M | -$36.0M | -$62.0M | $7.0M | $21.0M | -$97.0M |
| Operating Income Loss | $326.0M | $313.0M | $322.0M | $308.0M | $299.0M | $293.0M | $273.0M | $289.0M | $292.0M | $285.0M |
| Net Income Loss | $239.0M | $222.0M | $225.0M | $219.0M | $203.0M | $184.0M | $205.0M | $209.0M | $225.0M | $218.0M |
| Income Tax Expense Benefit | $67.0M | $63.0M | $64.0M | $67.0M | $67.0M | $66.0M | $63.0M | $66.0M | $67.0M | $67.0M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $306.0M | $285.0M | $289.0M | $286.0M | $270.0M | $250.0M | $268.0M | $275.0M | $292.0M | $285.0M |
| Gross Profit | $844.0M | $822.0M | $805.0M | $783.0M | $774.0M | $747.0M | $723.0M | $724.0M | $708.0M | $694.0M |
| Cost Of Goods And Services Sold | $560.0M | $549.0M | $527.0M | $531.0M | $514.0M | $499.0M | $532.0M | $529.0M | $517.0M | $525.0M |
| Comprehensive Income Net Of Tax | $199.0M | $343.0M | $283.0M | $288.0M | $177.0M | $157.0M | $146.0M | $216.0M | $246.0M | $121.0M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$40.0M | $121.0M | $58.0M | $69.0M | -$26.0M | -$27.0M | -$59.0M | $7.0M | $21.0M | -$97.0M |
| Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent | $0.00 | $0.00 | $1.0M | $1.0M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Amortization Of Intangible Assets | $9.0M | $11.0M | $12.0M | |||||||
| Interest Expense Nonoperating | $21.0M | $28.0M | $27.0M | $27.0M | $30.0M | $28.0M | $5.0M | |||
| Interest Expense | $30.0M | $28.0M | $5.0M | $0.00 | $0.00 | $0.00 | ||||
| Income Taxes Paid Net | $38.0M | $32.0M | $0.00 | |||||||
| Equity Method Investment Other Than Temporary Impairment | $15.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity * | $3.11B | $2.04B | $1.38B | $3.24B | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.03B | $1.10B | $762.0M | $0.00 | $0.00 | $0.00 |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $930.0M | $339.0M | $762.0M | $0.00 | $0.00 | |
| Property Plant And Equipment Net | $294.0M | $268.0M | $262.0M | $247.0M | $260.0M | |
| Goodwill | $2.84B | $2.69B | $2.53B | $2.48B | $2.50B | |
| Assets | $7.69B | $6.41B | $5.69B | $4.83B | $4.84B | |
| Prepaid Expense And Other Assets Current | $197.0M | $186.0M | $188.0M | $119.0M | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Other Liabilities Noncurrent | $558.0M | $517.0M | $410.0M | $462.0M | ||
| Other Assets Noncurrent | $605.0M | $523.0M | $398.0M | $343.0M | ||
| Minority Interest | $1.0M | $7.0M | $6.0M | $5.0M | ||
| Long Term Debt Noncurrent | $1.97B | $2.60B | $2.63B | $0.00 | ||
| Liabilities Current | $2.06B | $1.25B | $1.27B | $1.12B | ||
| Liabilities And Stockholders Equity | $7.69B | $6.41B | $5.69B | $4.83B | ||
| Inventory Net | $307.0M | $288.0M | $297.0M | $345.0M | ||
| Intangible Assets Net Excluding Goodwill | $524.0M | $535.0M | $427.0M | $479.0M | ||
| Common Stock Value | $2.0M | $2.0M | $2.0M | $0.00 | ||
| Cash And Cash Equivalents At Carrying Value | $2.03B | $1.10B | $762.0M | $0.00 | ||
| Assets Current | $3.43B | $2.39B | $2.07B | $1.28B | ||
| Allowance For Doubtful Accounts Receivable Current | $36.0M | $37.0M | $36.0M | $34.0M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$913.0M | -$1.07B | -$954.0M | -$954.0M | ||
| Accrued Liabilities Current | $940.0M | $850.0M | $834.0M | $683.0M | ||
| Accounts Receivable Net Current | $897.0M | $812.0M | $826.0M | $816.0M | ||
| Accounts Payable Trade Current | $416.0M | $395.0M | $431.0M | $440.0M | ||
| Retained Earnings Accumulated Deficit | $1.74B | $917.0M | $178.0M | $0.00 | ||
| Additional Paid In Capital Common Stock | $2.27B | $2.19B | $2.16B | $0.00 | ||
| Inventory Work In Process Net Of Reserves | ||||||
| Inventory Raw Materials Net Of Reserves | ||||||
| Inventory Finished Goods Net Of Reserves |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $2.85B | $2.65B | $2.30B | $1.95B | $1.67B | $1.48B | $1.04B | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.78B | $1.56B | $1.24B | $1.27B | $1.04B | $827.0M | $426.0M | $0.00 | $0.00 | $0.00 | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $138.0M | $65.0M | $0.00 | ||||||||||
| Property Plant And Equipment Net | $285.0M | $284.0M | $274.0M | $261.0M | $263.0M | $264.0M | $248.0M | ||||||
| Goodwill | $2.82B | $2.84B | $2.74B | $2.54B | $2.49B | $2.50B | $2.48B | ||||||
| Assets | $7.43B | $7.17B | $6.65B | $6.26B | $5.90B | $5.71B | $5.16B | ||||||
| Prepaid Expense And Other Assets Current | $205.0M | $187.0M | $177.0M | $185.0M | $175.0M | $167.0M | $102.0M | ||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Other Liabilities Noncurrent | $572.0M | $563.0M | $536.0M | $438.0M | $426.0M | $446.0M | $479.0M | ||||||
| Other Assets Noncurrent | $596.0M | $560.0M | $544.0M | $445.0M | $416.0M | $415.0M | $339.0M | ||||||
| Minority Interest | $1.0M | $8.0M | $7.0M | $6.0M | $6.0M | $6.0M | $5.0M | ||||||
| Long Term Debt Noncurrent | $1.97B | $2.67B | $2.63B | $2.64B | $2.62B | $2.62B | $2.60B | ||||||
| Liabilities Current | $2.04B | $1.28B | $1.17B | $1.23B | $1.19B | $1.16B | $1.03B | ||||||
| Liabilities And Stockholders Equity | $7.43B | $7.17B | $6.65B | $6.26B | $5.90B | $5.71B | $5.16B | ||||||
| Inventory Net | $340.0M | $329.0M | $310.0M | $326.0M | $312.0M | $308.0M | $316.0M | ||||||
| Intangible Assets Net Excluding Goodwill | $529.0M | $539.0M | $531.0M | $401.0M | $401.0M | $413.0M | $433.0M | ||||||
| Common Stock Value | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | ||||||
| Cash And Cash Equivalents At Carrying Value | $1.78B | $1.56B | $1.24B | $1.27B | $1.04B | $827.0M | $426.0M | ||||||
| Assets Current | $3.20B | $2.95B | $2.56B | $2.62B | $2.33B | $2.12B | $1.66B | ||||||
| Allowance For Doubtful Accounts Receivable Current | $37.0M | $39.0M | $37.0M | $35.0M | $34.0M | $35.0M | $36.0M | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$932.0M | -$892.0M | -$1.01B | -$938.0M | -$1.01B | -$981.0M | -$985.0M | ||||||
| Accrued Liabilities Current | $937.0M | $864.0M | $763.0M | $802.0M | $793.0M | $754.0M | $680.0M | ||||||
| Accounts Receivable Net Current | $875.0M | $878.0M | $832.0M | $839.0M | $803.0M | $815.0M | $816.0M | ||||||
| Accounts Payable Trade Current | $400.0M | $411.0M | $407.0M | $424.0M | $397.0M | $402.0M | $354.0M | ||||||
| Retained Earnings Accumulated Deficit | $1.52B | $1.31B | $1.11B | $717.0M | $521.0M | $340.0M | |||||||
| Additional Paid In Capital Common Stock | $2.26B | $2.23B | $2.20B | $2.17B | $2.15B | $2.12B | |||||||
| Inventory Work In Process Net Of Reserves | $48.0M | $48.0M | $43.0M | $39.0M | $43.0M | $43.0M | $43.0M | $42.0M | $45.0M | $51.0M | |||
| Inventory Raw Materials Net Of Reserves | $134.0M | $137.0M | $126.0M | $127.0M | $138.0M | $137.0M | $133.0M | $129.0M | $137.0M | $149.0M | |||
| Inventory Finished Goods Net Of Reserves | $158.0M | $144.0M | $141.0M | $122.0M | $145.0M | $132.0M | $132.0M | $126.0M | $134.0M | $145.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Share Based Compensation | $74.0M | $65.0M | $55.0M | $41.0M | $34.0M |
| Payments To Acquire Property Plant And Equipment | $63.0M | $55.0M | $54.0M | $34.0M | $54.0M |
| Payments For Proceeds From Other Investing Activities | $35.0M | $16.0M | $1.0M | $0.00 | $9.0M |
| Net Cash Provided By Used In Operating Activities | $1.08B | $875.0M | $963.0M | $870.0M | $896.0M |
| Net Cash Provided By Used In Investing Activities | -$98.0M | -$434.0M | -$55.0M | -$89.0M | -$97.0M |
| Net Cash Provided By Used In Financing Activities | -$102.0M | -$65.0M | -$135.0M | -$781.0M | -$799.0M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $40.0M | $48.0M | $54.0M | $5.0M | $21.0M |
| Increase Decrease In Inventories | $6.0M | -$3.0M | -$52.0M | $38.0M | $75.0M |
| Increase Decrease In Accrued Liabilities | $110.0M | $29.0M | -$7.0M | $46.0M | -$41.0M |
| Increase Decrease In Accounts Receivable | $50.0M | -$3.0M | -$2.0M | $88.0M | $14.0M |
| Increase Decrease In Accounts Payable | $8.0M | -$29.0M | -$1.0M | $23.0M | $65.0M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $53.0M | -$37.0M | -$11.0M | $0.00 | $0.00 |
| Proceeds From Payments To Parent | $0.00 | $0.00 | -$147.0M | -$781.0M | -$800.0M |
| Payments Of Dividends | $109.0M | $89.0M | $0.00 | $0.00 | |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 22.0M | 24.0M | 4.0M | 0.00 | 0.00 |
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $16.0M | $15.0M | $9.0M | ||||||||
| Payments To Acquire Property Plant And Equipment | $15.0M | $13.0M | $9.0M | ||||||||
| Payments For Proceeds From Other Investing Activities | -$4.0M | $10.0M | $0.00 | ||||||||
| Net Cash Provided By Used In Operating Activities | $157.0M | $115.0M | $156.0M | ||||||||
| Net Cash Provided By Used In Investing Activities | -$11.0M | -$23.0M | -$9.0M | ||||||||
| Net Cash Provided By Used In Financing Activities | -$26.0M | -$20.0M | -$147.0M | ||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $19.0M | $9.0M | $9.0M | ||||||||
| Increase Decrease In Inventories | $20.0M | $13.0M | $2.0M | ||||||||
| Increase Decrease In Accrued Liabilities | -$71.0M | -$76.0M | -$57.0M | ||||||||
| Increase Decrease In Accounts Receivable | $9.0M | -$4.0M | -$1.0M | ||||||||
| Increase Decrease In Accounts Payable | $10.0M | -$26.0M | -$33.0M | ||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $18.0M | -$7.0M | $0.00 | ||||||||
| Proceeds From Payments To Parent | $0.00 | -$147.0M | |||||||||
| Payments Of Dividends | $27.0M | $22.0M | $0.00 | ||||||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 1.0M | 2.0M | |||||||||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | $529.0M | $517.0M | $494.0M | $485.0M | $491.0M | $481.0M | $474.0M | $472.0M | $462.0M | $460.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 248.3M | 247.3M | 246.4M | 246.3M | 246.3M |
| Weighted Average Number Of Diluted Shares Outstanding | 250.3M | 249.6M | 246.8M | 246.3M | 246.3M |
| Earnings Per Share Diluted | $3.76 | $3.34 | $3.40 | $3.43 | $3.50 |
| Earnings Per Share Basic | $3.79 | $3.37 | $3.41 | $3.43 | $3.50 |
| Common Stock Shares Outstanding | 248.4M | 247.4M | 246.3M | 100.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 15.0M | 15.0M | 15.0M | 100.00 | |
| Common Stock Shares Issued | 248.4M | 247.4M | 246.3M | 100.00 | |
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 100.00 | |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | |
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 248.5M | 248.2M | 247.9M | 247.4M | 247.2M | 246.9M | 246.3M | 246.3M | 246.3M | 246.3M | |
| Weighted Average Number Of Diluted Shares Outstanding | 250.6M | 249.9M | 250.1M | 250.0M | 249.3M | 248.8M | 246.3M | 246.3M | 246.3M | 246.3M | |
| Earnings Per Share Diluted | $0.95 | $0.89 | $0.90 | $0.88 | $0.81 | $0.74 | $0.83 | $0.85 | $0.91 | $0.89 | |
| Earnings Per Share Basic | $0.96 | $0.89 | $0.91 | $0.89 | $0.82 | $0.75 | $0.83 | $0.85 | $0.91 | $0.89 | |
| Common Stock Shares Outstanding | 248.3M | 248.1M | 247.8M | 247.2M | 247.1M | 246.8M | 246.3M | 0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Authorized | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | ||||
| Common Stock Shares Issued | 248.3M | 248.1M | 247.8M | 247.2M | 247.1M | 246.8M | 246.3M | ||||
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | ||||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Depreciation | $42.0M | $40.0M | $39.0M | $40.0M | $44.0M |
| Interest Paid Net | $138.0M | $137.0M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|
| Depreciation | $10.0M | $10.0M | $10.0M |
| Interest Paid Net | $57.0M | $57.0M | $0.00 |
Most recent annual filing with the SEC: February 20, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.